Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:30 am Sale | 2022-12-31 | 13G | Vyant Bio, Inc. VYNT | FOD Capital LLC | 0 0.000% | -294,987 (Position Closed) | Filing History |
| 2022-02-14 1:04 pm Purchase | 2021-12-31 | 13G | Vyant Bio, Inc. VYNT | FOD Capital LLC | 294,987 5.090% | 294,987 (New Position) | Filing History |
| 2022-02-11 07:36 am Unchanged | 2021-12-31 | 13G | Vyant Bio, Inc. VYNT | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-10 6:25 pm Purchase | 2021-12-31 | 13G | Vyant Bio, Inc. VYNT | Renaissance Technologies LLC | 19,268 0.330% | 19,268 (New Position) | Filing History |
| 2022-02-09 5:05 pm Purchase | 2021-12-31 | 13G | Vyant Bio, Inc. VYNT | Lind Global Macro Fund LP | 137,931 2.300% | 137,931 (New Position) | Filing History |
| 2022-02-07 4:39 pm Purchase | 2021-12-31 | 13G | Vyant Bio, Inc. VYNT | BIGGER CAPITAL FUND L P | 48,966 11.000% | 48,966 (New Position) | Filing History |
| 2021-02-25 3:05 pm Unchanged | 2021-02-11 | 13D | CANCER GENETICS INC CGIX | FiveT Investment Management Ltd | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-10 9:43 pm Purchase | 2020-12-31 | 13G | CANCER GENETICS INC CGIX | Renaissance Technologies LLC | 242,801 5.940% | 74,769 (+44.50%) | Filing History |
| 2021-02-10 9:26 pm Sale | 2020-12-31 | 13G | CANCER GENETICS INC CGIX | Ionic Ventures, LLC | 0 0.000% | -250,000 (Position Closed) | Filing History |
| 2021-02-09 06:17 am Purchase | 2021-02-01 | 13G | CANCER GENETICS INC CGIX | Mitchell P. Kopin | 710,905 9.990% | 710,905 (New Position) | Filing History |
| 2021-02-08 4:32 pm Purchase | 2021-01-28 | 13G | CANCER GENETICS INC CGIX | BIGGER CAPITAL FUND L P | 689,656 9.700% | 689,656 (New Position) | Filing History |
| 2021-02-03 4:46 pm Purchase | 2021-02-01 | 13G | CANCER GENETICS INC CGIX | Lind Global Macro Fund LP | 710,656 9.900% | 710,656 (New Position) | Filing History |
| 2021-01-14 3:44 pm Sale | 2020-12-31 | 13G | CANCER GENETICS INC CGIX | Alpha Capital Anstalt | 85 0.002% | -227,187 (-99.96%) | Filing History |
| 2020-11-09 10:39 am Purchase | 2020-10-29 | 13D | CANCER GENETICS INC CGIX | FiveMore Fund Ltd | 155,542 3.820% | 155,542 (New Position) | Filing History |
| 2020-11-02 06:02 am Purchase | 2020-11-02 | 13G | CANCER GENETICS INC CGIX | Ionic Ventures, LLC | 250,000 6.460% | 250,000 (New Position) | Filing History |
| 2020-10-30 09:08 am Purchase | 2020-10-28 | 13G | CANCER GENETICS INC CGIX | Alpha Capital Anstalt | 227,272 5.870% | 227,272 (New Position) | Filing History |